Filing Details

Accession Number:
0001209191-20-054839
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-14 19:27:04
Reporting Period:
2020-10-14
Accepted Time:
2020-10-14 19:27:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS Pharmaceutical Preparations (2834) 475461709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740847 Bryan Giraudo 3013 Science Park Road
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-14 3,000 $10.01 7,121 No 4 P Indirect By family trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By family trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 70,379 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $9.41 to $10.31 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request.
  2. Includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.